Medical management to prevent recurrent nephrolithiasis in adults: A systematic review for an American College of Physicians Clinical Guideline

Annals of Internal Medicine

Volumn 158, Issue 7, 2013, Pages 535-543

  Fink, Howard A ^a   Wilt, Timothy J ^a   Eidman, Keith E ^b   Garimella, Pranav S ^c   MacDonald, Roderick ^a   Rutks, Indulis R ^a   Brasure, Michelle ^d   Kane, Robert L ^d   Ouellette, Jeannine ^d   Monga, Manoj ^e  

^a VA MEDICAL CENTER   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c TUFTS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOHYDROXAMIC ACID; ALLOPURINOL; CHLORTALIDONE; CITRIC ACID; HYDROCHLOROTHIAZIDE; INDAPAMIDE; PLACEBO; THIAZIDE DIURETIC AGENT;

BIBLIOGRAPHIC DATABASE; BIOCHEMISTRY; CALCIUM STONE; COCHRANE LIBRARY; DATA EXTRACTION; DIETARY FIBER; DIETARY INTAKE; ENGLISH AS A SECOND LANGUAGE; EXTRACORPOREAL LITHOTRIPSY; FLUID INTAKE; HUMAN; MEDICAL SOCIETY; MEDLINE; META ANALYSIS; NEPHROLITHIASIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RECURRENT DISEASE; RECURRENT NEPHROLITHIASIS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADULT; ALLOPURINOL; ANTIMETABOLITES; CARBONATED BEVERAGES; CITRATES; DRINKING; ENZYME INHIBITORS; FLUID THERAPY; HUMANS; HYDROXAMIC ACIDS; NEPHROLITHIASIS; PRACTICE GUIDELINES AS TOPIC; RECURRENCE; THIAZIDES; TREATMENT OUTCOME;

EID: 84875753302     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-7-201304020-00005     Document Type: Review

References (63)

1. Pearle MS, Calhoun EA, Curhan GC; Urologic Diseases of America Project. Urologic diseases in America project: urolithiasis. J Urol. 2005;173:848-57.
2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-23.
3. Boyce CJ, Pickhardt PJ, Lawrence EM, Kim DH, Bruce RJ. Prevalence of urolithiasis in asymptomatic adults: objective determination using low dose noncontrast computerized tomography. J Urol. 2010;183:1017-21.
4. Bansal AD, Hui J, Goldfarb DS. Asymptomatic nephrolithiasis detected by ultrasound. Clin J Am Soc Nephrol. 2009;4:680-4.
5. Inci K, Sahin A, Islamoglu E, Eren MT, Bakkaloglu M, Ozen H. Prospective long-term followup of patients with asymptomatic lower pole caliceal stones. J Urol. 2007;177:2189-92.
6. Burgher A, Beman M, Holtzman JL, Monga M. Progression of nephrolithi-asis: long-term outcomes with observation of asymptomatic calculi. J Endourol. 2004;18:534-9.
7. Glowacki LS, Beecroft ML, Cook RJ, Pahl D, Churchill DN. The natural history of asymptomatic urolithiasis. J Urol. 1992;147:319-21.
8. Uribarri J, Oh MS, Carroll HJ. The first kidney stone. Ann Intern Med. 1989;111:1006-9.
9. Saigal CS, Joyce G, Timilsina AR; Urologic Diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportu-nity for disease management? Kidney Int. 2005;68:1808-14.
10. Moe OW. Kidney stones: pathophysiology and medical management. Lan-cet. 2006;367:333-44.
11. Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol. 2010;23 Suppl 16:S165-9.
12. Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1995;98:50-9.
13. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med. 2004;164:885-91.
14. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833-8.
15. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Com-parison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997; 126:497-504.
16. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol. 2004;15:3225-32.
17. Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones. Kidney Int. 2008;73:207-12.
18. Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M. Risk of renal stone events in primary hyperparathyroidism be-fore and after parathyroid surgery: controlled retrospective follow up study. BMJ. 2002;325:807.
19. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455-62.
20. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68:1230-5.
21. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis. 2002;40:37-42.
22. Ciacci C, Spagnuolo G, Tortora R, Bucci C, Franzese D, Zingone F, et al. Urinary stone disease in adults with celiac disease: prevalence, incidence and urinary determinants. J Urol. 2008;180:974-9.
23. Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009;56:72-80.
24. Pearle MS, Roehrborn CG, Pak CY. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999;13:679-85.
25. Escribano J, Balaguer A, Pagone F, Feliu A, Roqué I Figuls M. Pharmaco-logical interventions for preventing complications in idiopathic hypercalciuria. Cochrane Database Syst Rev. 2009:CD004754.
26. Kairaitis L; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Kidney stones: prevention of recurrent calcium nephrolithiasis. Nephrology (Carlton). 2007;12 Suppl 1:S11-20.
27. Mattle D, Hess B. Preventive treatment of nephrolithiasis with alkali citrate-a critical review. Urol Res. 2005;33:73-9.
28. Becker G; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Kidney stones: cystine stones. Nephrology (Carlton). 2007;12 Suppl 1:S4-10.
29. Becker G; Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Kidney stones: uric acid stones. Nephrology (Carlton). 2007;12 Suppl 1:S21-5.
30. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collabora-tion; 2011. Accessed at www.cochrane-handbook.org on 6 February 2013.
31. Schulz KF, Grimes DA. Allocation concealment in randomised trials: de-fending against deciphering. Lancet. 2002;359:614-8.
32. Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. AHRQ series paper 5: grading the strength of a body of evidence when compar-ing medical interventions-Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol. 2010;63:513-23.
33. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
34. Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158:2069-73.
35. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77-84.
36. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839-43.
37. Kocvara R, Plasgura P, Petrík A, Louzenský G, Bartonícková K, Dvorácek J. A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int. 1999;84:393-8.
38. Sarica K, Inal Y, Erturhan S, Yagci F. The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res. 2006; 34:184-9.
39. Shuster J, Jenkins A, Logan C, Barnett T, Riehle R, Zackson D, et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. 1992;45:911-6.
40. Dussol B, Iovanna C, Rotily M, Morange S, Leonetti F, Dupuy P, et al. A randomized trial of low-animal-protein or high-fiber diets for secondary preven-tion of calcium nephrolithiasis. Nephron Clin Pract. 2008;110:c185-94.
41. Hiatt RA, Ettinger B, Caan B, Quesenberry CP Jr, Duncan D, Citron JT. Randomized controlled trial of a low animal protein, high fiber diet in the pre-vention of recurrent calcium oxalate kidney stones. Am J Epidemiol. 1996;144: 25-33.
42. Ettinger B, Citron JT, Livermore B, Dolman LI. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol. 1988;139:679-84.
43. Laerum E, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand. 1984;215:383-9.
44. Scholz D, Schwille PO, Sigel A. Double-blind study with thiazide in recur-rent calcium lithiasis. J Urol. 1982;128:903-7.
45. Fernández-Rodríguez A, Arrabal-Martín M, García-Ruiz MJ, Arrabal-Polo MA, Pichardo-Pichardo S, Zuluaga-Gómez A. [The role of thiazides in the prophylaxis of recurrent calcium lithiasis]. Actas Urol Esp. 2006;30:305-9.
46. Borghi L, Meschi T, Guerra A, Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol. 1993;22 Suppl 6:S78-86.
47. Ahlstrand C, Sandvall K, Tiselius HG, eds. Prophylactic treatment of cal-cium stone formers with hydrochlorothiazide and magnesium. Edsbruk, Sweden: Akademitryck; 1996.
48. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CY. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithi-asis. J Urol. 1993;150:1761-4.
49. Soygür T, Akbay A, Küpeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol. 2002;16: 149-52.
50. Hofbauer J, Höbarth K, Szabo N, Marberger M. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis-a prospective randomized study. Br J Urol. 1994;73:362-5.
51. Premgamone A, Sriboonlue P, Disatapornjaroen W, Maskasem S, Sinsu-pan N, Apinives C. A long-term study on the efficacy of a herbal plant, Ortho-siphon grandiflorus, and sodium potassium citrate in renal calculi treatment. Southeast Asian J Trop Med Public Health. 2001;32:654-60.
52. Lojanapiwat B, Tanthanuch M, Pripathanont C, Ratchanon S, Srinualnad S, Taweemonkongsap T, et al. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Int Braz J Urol. 2011;37:611-6.
53. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986; 315:1386-9.
54. Miano L, Petta S, Galatioto GP, Gullucci M. A placebo controlled double-blind study of allopurinol in severe recurrent idiopathic renal lithiasis. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W, eds. Urolithiasis and Related Clinical Research. New York: Plenum; 1985:521-4.
55. Robertson WG, Peacock M, Sepby PL, Williams RE, Clark P, Chisholm GD, et al. A multicentre trial to evaluate three treatments for recurrent idiopathic calcium stone disease-a preliminary report. New York: Plenum; 1985.
56. Smith MJ. Placebo versus allopurinol for renal calculi. J Urol. 1977;117: 690-2.
57. Smith MJ. Placebo versus allopurinol for recurrent urinary calculi. Proc Eur Dial Transplant Assoc. 1983;20:422-6.
58. Griffith DP, Khonsari F, Skurnick JH, James KE. A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced uri-nary stones in spinal cord injury patients. J Urol. 1988;140:318-24.
59. Griffith DP, Gleeson MJ, Lee H, Longuet R, Deman E, Earle N. Random-ized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treat-ment of infection-induced urinary calculi. Eur Urol. 1991;20:243-7.
60. Williams JJ, Rodman JS, Peterson CM. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N Engl J Med. 1984;311:760-4.
61. Laerum E. Metabolic effects of thiazide versus placebo in patients under long-term treatment for recurrent urolithiasis. Scand J Urol Nephrol. 1984;18: 143-9.
62. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int. 2001;59:2290-8.
63. Trochim W. Regression to the Mean. Web Center for Social Research Meth-ods Web site. Updated 20 October 2006. Accessed at www.socialresearchmethods.net/kb/regrmean.php on 6 February 2013.